Autism: Clinical Trials

8 trials for Autism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 recruiting. 8 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 28Recruiting 8
Phase 31Recruiting 1

Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism
Terpenes-Enriched CBD-Predominant Oil, Placebo, Terpenes-Enriched CBD Oil (THC-Free) - Autism, Autism Spectrum Disorder
Phase 2RecruitingBazelet Nehushtan LtD.782025-10-052025-11-19
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
Sertraline, Placebo - Neurodevelopmental Disorders, Autism
Phase 2RecruitingHolland Bloorview Kids Rehabilitation Hospital1302024-09-162026-07-27
Trial of Zolpidem for Sleep in Children With Autism
Zolpidem, Placebo - Autism, Autism Spectrum Disorder
Phase 2RecruitingStanford University262023-08-092026-03-27
Trial of Diphenhydramine for Sleep in Children With Autism
Diphenhydramine, Placebo - Autism, Autism Spectrum Disorder
Phase 2RecruitingStanford University262023-08-092026-03-27
Trial of Suvorexant for Sleep in Children With Autism
Suvorexant, Placebo - Autism, Autism Spectrum Disorder
Phase 2RecruitingStanford University262023-08-092026-03-27
The Impact of a Virtual Magic Trick Training Program
magic trick training - Autism, Pervasive Developmental Disorder
Phase 2RecruitingUniversity of Alabama at Birmingham602023-03-272026-02-06
Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders
PostbiotiX Comfort®, Control - Autism, Autism Disorder
Phase 2 / Phase 3RecruitingFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta902023-03-212026-03-04
A Study of Esomeprazole in Children With Autism
Esomeprazole - Autism, Autism Spectrum Disorder
Phase 2RecruitingStanford University252019-05-292026-11-05

Narrower conditions

Autistic Disorder (8)  ·  Autism Spectrum Disorder (7)  ·  22q11 Deletion Syndrome (1)  ·  Anxiety Disorders (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Child Development Disorders, Pervasive (1)  ·  DiGeorge Syndrome (1)  ·  Fragile X Syndrome (1)  ·  Neurodevelopmental Disorders (1)  ·  Tic Disorders (1)  ·  Tourette Syndrome (1)  ·  Tuberous Sclerosis (1)

Broader conditions

Mental Disorders (8)  ·  Child Development Disorders, Pervasive (7)  ·  Neurodevelopmental Disorders (7)  ·  Abnormalities, Multiple (1)  ·  Attention Deficit and Disruptive Behavior Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chromosome Disorders (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Craniofacial Abnormalities (1)

Interventions

Diphenhydramine (1)  ·  Esomeprazole (1)  ·  Selective Serotonin Reuptake Inhibitors (1)  ·  Sertraline (1)  ·  Zolpidem (1)  ·  suvorexant (1)

Sponsors

Stanford University (4)  ·  Bazelet Nehushtan LtD. (1)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1)  ·  Holland Bloorview Kids Rehabilitation Hospital (1)  ·  University of Alabama at Birmingham (1)

Countries

United States (5)  ·  Canada (1)  ·  Israel (1)  ·  Italy (1)

Top investigators

Antonio Y. Hardan, MD (3)  ·  Antonio Hardan, MD (1)  ·  Dr. Evdokia Anagnostou (1)  ·  Hon Yuen, PhD (1)  ·  Stefano D'Arrigo, MD (1)

NIH funding

P50HD109861 (3)